Our cell-based bioassays are developed following industry guidelines on bioanalytical method validation.
Physiologically relevant liver disease models that can be generated at scale for modeling, assay development and screening.
By combining our expertise at generating iPSC-derived hepatocyte cellular models of disease with our wide panel of bespoke bioassays. We work as partners with your team to design and implement in-house screening of small molecule and advanced genetic therapies, so you can advance your program at speed.
Copyright © 2022 Definigen